e10vq
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended April 2, 2011
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 1-5129
MOOG INC.
(Exact name of registrant as specified in its charter)
|
|
|
New York State
|
|
16-0757636 |
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.) |
|
|
|
East Aurora, New York
|
|
14052-0018 |
(Address of principal executive offices)
|
|
(Zip Code) |
Telephone number including area code: (716) 652-2000
Former name, former address and former fiscal year, if changed since last report.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that
the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation
S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of large accelerated filer, accelerated
filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer þ | Accelerated filer o | Non-accelerated filer o (Do not check if a smaller reporting company) |
Smaller reporting company o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ
The number of shares outstanding of each class of common stock as of May 4, 2011 was:
Class A common stock, $1.00 par value 41,417,225 shares
Class B common stock, $1.00 par value 3,998,182 shares
MOOG
Inc.
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
2
PART I FINANCIAL INFORMATION
Item 1. Financial Statements.
Moog Inc.
Consolidated Condensed Balance Sheets
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
April 2, |
|
October 2, |
(dollars in thousands) |
|
2011 |
|
2010 |
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
100,020 |
|
|
$ |
112,421 |
|
Receivables |
|
|
643,654 |
|
|
|
619,861 |
|
Inventories |
|
|
487,443 |
|
|
|
460,857 |
|
Other current assets |
|
|
105,901 |
|
|
|
99,140 |
|
|
|
|
TOTAL CURRENT ASSETS |
|
|
1,337,018 |
|
|
|
1,292,279 |
|
|
|
|
|
|
|
|
|
|
PROPERTY, PLANT AND EQUIPMENT, net of accumulated depreciation of $491,302
and $457,916,
respectively |
|
|
492,518 |
|
|
|
486,944 |
|
GOODWILL |
|
|
709,353 |
|
|
|
704,816 |
|
INTANGIBLE ASSETS, net |
|
|
195,644 |
|
|
|
205,874 |
|
OTHER ASSETS |
|
|
24,304 |
|
|
|
22,221 |
|
|
|
|
TOTAL ASSETS |
|
$ |
2,758,837 |
|
|
$ |
2,712,134 |
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES |
|
|
|
|
|
|
|
|
|
Notes payable |
|
$ |
1,554 |
|
|
$ |
1,991 |
|
Current installments of long-term debt |
|
|
2,300 |
|
|
|
5,405 |
|
Accounts payable |
|
|
152,083 |
|
|
|
154,321 |
|
Customer advances |
|
|
79,974 |
|
|
|
74,703 |
|
Contract loss reserves |
|
|
40,973 |
|
|
|
40,810 |
|
Other accrued liabilities |
|
|
208,179 |
|
|
|
202,244 |
|
|
|
|
TOTAL CURRENT LIABILITIES |
|
|
485,063 |
|
|
|
479,474 |
|
|
|
|
|
|
|
|
|
|
LONG-TERM DEBT, excluding current installments |
|
|
|
|
|
|
|
|
Senior debt |
|
|
335,978 |
|
|
|
378,707 |
|
Senior subordinated notes |
|
|
378,605 |
|
|
|
378,613 |
|
LONG-TERM PENSION AND RETIREMENT OBLIGATIONS |
|
|
272,884 |
|
|
|
281,830 |
|
DEFERRED INCOME TAXES |
|
|
76,381 |
|
|
|
69,541 |
|
OTHER LONG-TERM LIABILITIES |
|
|
2,974 |
|
|
|
3,013 |
|
|
|
|
TOTAL LIABILITIES |
|
|
1,551,885 |
|
|
|
1,591,178 |
|
|
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Common stock |
|
|
51,280 |
|
|
|
51,280 |
|
Other shareholders equity |
|
|
1,155,672 |
|
|
|
1,069,676 |
|
|
|
|
TOTAL SHAREHOLDERS EQUITY |
|
|
1,206,952 |
|
|
|
1,120,956 |
|
|
|
|
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY |
|
$ |
2,758,837 |
|
|
$ |
2,712,134 |
|
|
|
|
See accompanying Notes to Consolidated Condensed Financial Statements.
3
Moog Inc.
Consolidated Condensed Statements of Earnings
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
April 2, |
|
April 3, |
(dollars in thousands, except per share data) |
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
NET SALES |
|
$ |
574,226 |
|
|
$ |
510,488 |
|
|
$ |
1,128,660 |
|
|
$ |
1,005,666 |
|
COST OF SALES |
|
|
406,978 |
|
|
|
362,587 |
|
|
|
796,859 |
|
|
|
713,363 |
|
|
|
|
GROSS PROFIT |
|
|
167,248 |
|
|
|
147,901 |
|
|
|
331,801 |
|
|
|
292,303 |
|
Research and development |
|
|
28,154 |
|
|
|
25,504 |
|
|
|
51,629 |
|
|
|
49,386 |
|
Selling, general and administrative |
|
|
86,974 |
|
|
|
76,098 |
|
|
|
172,757 |
|
|
|
154,225 |
|
Restructuring |
|
|
518 |
|
|
|
1,320 |
|
|
|
576 |
|
|
|
3,139 |
|
Interest |
|
|
8,970 |
|
|
|
9,248 |
|
|
|
18,181 |
|
|
|
19,976 |
|
Other |
|
|
(673 |
) |
|
|
236 |
|
|
|
(427 |
) |
|
|
630 |
|
|
|
|
EARNINGS BEFORE INCOME TAXES |
|
|
43,305 |
|
|
|
35,495 |
|
|
|
89,085 |
|
|
|
64,947 |
|
INCOME TAXES |
|
|
12,690 |
|
|
|
10,494 |
|
|
|
25,063 |
|
|
|
18,385 |
|
|
|
|
NET EARNINGS |
|
$ |
30,615 |
|
|
$ |
25,001 |
|
|
$ |
64,022 |
|
|
$ |
46,562 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET EARNINGS PER SHARE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.67 |
|
|
$ |
0.55 |
|
|
$ |
1.41 |
|
|
$ |
1.03 |
|
Diluted |
|
$ |
0.66 |
|
|
$ |
0.55 |
|
|
$ |
1.39 |
|
|
$ |
1.02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AVERAGE COMMON SHARES OUTSTANDING |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
45,419,121 |
|
|
|
45,374,912 |
|
|
|
45,404,006 |
|
|
|
45,349,131 |
|
Diluted |
|
|
46,058,991 |
|
|
|
45,730,252 |
|
|
|
45,982,772 |
|
|
|
45,661,564 |
|
|
|
|
See accompanying Notes to Consolidated Condensed Financial Statements.
4
Moog Inc.
Consolidated Condensed Statements of Cash Flows
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
(dollars in thousands) |
|
2011 |
|
2010 |
|
CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
|
|
|
|
|
|
Net earnings |
|
$ |
64,022 |
|
|
$ |
46,562 |
|
Adjustments to reconcile net earnings to net cash provided
by operating activities: |
|
|
|
|
|
|
|
|
Depreciation |
|
|
31,873 |
|
|
|
29,954 |
|
Amortization |
|
|
15,099 |
|
|
|
14,859 |
|
Provisions for non-cash losses on contracts, inventories and receivables |
|
|
32,119 |
|
|
|
19,310 |
|
Equity-based compensation expense |
|
|
5,175 |
|
|
|
3,678 |
|
Other |
|
|
1,576 |
|
|
|
2,084 |
|
Changes in assets and liabilities providing cash, excluding the
effects of acquisitions: |
|
|
|
|
|
|
|
|
Receivables |
|
|
(17,581 |
) |
|
|
(27,782 |
) |
Inventories |
|
|
(30,843 |
) |
|
|
7,348 |
|
Accounts payable |
|
|
(5,144 |
) |
|
|
3,854 |
|
Customer advances |
|
|
4,542 |
|
|
|
5,606 |
|
Accrued expenses |
|
|
(28,844 |
) |
|
|
(21,517 |
) |
Accrued income taxes |
|
|
11,769 |
|
|
|
6,606 |
|
Pension assets and liabilities |
|
|
(3,237 |
) |
|
|
(7,293 |
) |
Other assets and liabilities |
|
|
(4,581 |
) |
|
|
564 |
|
|
|
|
NET CASH PROVIDED BY OPERATING ACTIVITIES |
|
|
75,945 |
|
|
|
83,833 |
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES |
|
|
|
|
|
|
|
|
Acquisitions of businesses, net of acquired cash |
|
|
(3,073 |
) |
|
|
(369 |
) |
Purchase of property, plant and equipment |
|
|
(34,888 |
) |
|
|
(27,997 |
) |
Other |
|
|
160 |
|
|
|
(212 |
) |
|
|
|
NET CASH USED BY INVESTING ACTIVITIES |
|
|
(37,801 |
) |
|
|
(28,578 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|
Net repayments of notes payable |
|
|
(505 |
) |
|
|
(12,871 |
) |
Net repayments of revolving lines of credit |
|
|
(39,798 |
) |
|
|
(32,209 |
) |
Payments on long-term debt |
|
|
(7,066 |
) |
|
|
(2,109 |
) |
Excess tax benefits from equity-based payment arrangements |
|
|
135 |
|
|
|
53 |
|
Other financing transactions |
|
|
(5,770 |
) |
|
|
1,083 |
|
|
|
|
NET CASH USED BY FINANCING ACTIVITIES |
|
|
(53,004 |
) |
|
|
(46,053 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash |
|
|
2,459 |
|
|
|
(2,097 |
) |
|
|
|
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS |
|
|
(12,401 |
) |
|
|
7,105 |
|
Cash and cash equivalents at beginning of period |
|
|
112,421 |
|
|
|
81,493 |
|
|
|
|
CASH AND CASH EQUIVALENTS AT END OF PERIOD |
|
$ |
100,020 |
|
|
$ |
88,598 |
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH PAID FOR: |
|
|
|
|
|
|
|
|
Interest |
|
$ |
17,629 |
|
|
$ |
19,395 |
|
Income taxes, net of refunds |
|
|
10,939 |
|
|
|
8,305 |
|
|
|
|
See accompanying Notes to Consolidated Condensed Financial Statements.
5
Moog Inc.
Notes to Consolidated Condensed Financial Statements
Six Months Ended April 2, 2011
(Unaudited)
(dollars in thousands, except per share data)
Note 1 Basis of Presentation
The accompanying unaudited consolidated condensed financial statements have been prepared by
management in accordance with U.S. generally accepted accounting principles for interim financial
information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion
of management, all adjustments consisting of normal recurring adjustments considered necessary for
the fair presentation of results for the interim period have been included. The results of
operations for the six months ended April 2, 2011 are not necessarily indicative of the results
expected for the full year. The accompanying unaudited consolidated condensed financial statements
should be read in conjunction with the financial statements and notes thereto included in our Form
10-K for the fiscal year ended October 2, 2010. All references to years in these financial
statements are to fiscal years.
Note 2 Acquisitions
During the six months ended April 2, 2011, we completed one business combination within our
Aircraft Controls segment for $3,073 in cash. This acquisition complements our military aftermarket
business.
In 2010, we completed four business combinations within three of our segments. We completed one
acquisition in our Aircraft Controls segment for $8,100 in cash, issuance of a $1,200 unsecured
note and contingent consideration with an initial fair value of $1,400. This acquisition
complements our military aftermarket business. We acquired two businesses in our Space and Defense
Controls segment for $20,273, net of cash acquired, issuance of a $1,000 unsecured note and
contingent consideration with an initial fair value of $1,600. One business specializes in turret
design, fire control systems and vehicle electronics and the other expands our capabilities in the
security and surveillance market. We completed one acquisition in our Industrial Systems segment
for $1,050 in cash and issuance of a $150 unsecured note. Combined sales of these acquisitions for
the 2009 calendar year were approximately $34,000. The purchase price allocations for the 2010
acquisitions are complete with the exception of income taxes for one of the Space and Defense
Controls acquisitions.
Note 3 Inventories
|
|
|
|
|
|
|
|
|
|
|
April 2, |
|
October 2, |
|
|
2011 |
|
2010 |
|
Raw materials and purchased parts |
|
$ |
185,967 |
|
|
$ |
179,375 |
|
Work in progress |
|
|
232,151 |
|
|
|
221,128 |
|
Finished goods |
|
|
69,325 |
|
|
|
60,354 |
|
|
Total |
|
$ |
487,443 |
|
|
$ |
460,857 |
|
|
6
Note 4 Goodwill and Intangible Assets
The changes in the carrying amount of goodwill are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of |
|
Adjustment |
|
Foreign |
|
Balance as of |
|
|
October 2, |
|
To Prior Year |
|
Currency |
|
April 2, |
|
|
2010 |
|
Acquisitions |
|
Translation |
|
2011 |
|
Aircraft Controls |
|
$ |
173,507 |
|
|
$ |
(903 |
) |
|
$ |
1,150 |
|
|
$ |
173,754 |
|
Space and Defense Controls |
|
|
121,623 |
|
|
|
22 |
|
|
|
251 |
|
|
|
121,896 |
|
Industrial Systems |
|
|
122,120 |
|
|
|
41 |
|
|
|
2,119 |
|
|
|
124,280 |
|
Components |
|
|
160,896 |
|
|
|
|
|
|
|
1,615 |
|
|
|
162,511 |
|
Medical Devices |
|
|
126,670 |
|
|
|
(138 |
) |
|
|
380 |
|
|
|
126,912 |
|
|
Total |
|
$ |
704,816 |
|
|
$ |
(978 |
) |
|
$ |
5,515 |
|
|
$ |
709,353 |
|
|
The components of acquired intangible assets are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 2, 2011 |
|
October 2, 2010 |
|
|
Weighted |
|
Gross |
|
|
|
|
|
Gross |
|
|
|
|
Average |
|
Carrying |
|
Accumulated |
|
Carrying |
|
Accumulated |
|
|
Life (years) |
|
Amount |
|
Amortization |
|
Amount |
|
Amortization |
|
Customer-related |
|
|
10 |
|
|
$ |
151,018 |
|
|
$ |
(57,675 |
) |
|
$ |
148,722 |
|
|
$ |
(49,781 |
) |
Program-related |
|
|
18 |
|
|
|
64,902 |
|
|
|
(7,389 |
) |
|
|
63,796 |
|
|
|
(5,275 |
) |
Technology-related |
|
|
9 |
|
|
|
55,620 |
|
|
|
(25,577 |
) |
|
|
54,743 |
|
|
|
(22,117 |
) |
Marketing-related |
|
|
9 |
|
|
|
22,392 |
|
|
|
(12,731 |
) |
|
|
22,256 |
|
|
|
(11,548 |
) |
Contract-related |
|
|
3 |
|
|
|
3,348 |
|
|
|
(1,671 |
) |
|
|
3,312 |
|
|
|
(1,104 |
) |
Artistic-related |
|
|
10 |
|
|
|
25 |
|
|
|
(24 |
) |
|
|
25 |
|
|
|
(22 |
) |
|
Acquired intangible assets |
|
|
11 |
|
|
$ |
297,305 |
|
|
$ |
(105,067 |
) |
|
$ |
292,854 |
|
|
$ |
(89,847 |
) |
|
All acquired intangible assets other than goodwill are being amortized. Customer-related
intangible assets primarily consist of customer relationships. Program-related intangible assets
consist of long-term programs. Technology-related intangible assets primarily consist of
technology, patents, intellectual property and engineering drawings. Marketing-related intangible
assets primarily consist of trademarks, trade names and non-compete agreements. Contract-related
intangible assets consist of favorable operating lease terms.
Amortization of acquired intangible assets was $7,012 and $13,956 for the three and six months
ended April 2, 2011 and $6,869 and $13,977 for the three and six months ended April 3, 2010. Based
on acquired intangible assets recorded at April 2, 2011, amortization is expected to be
approximately $28,000 in 2011, $27,000 in 2012, $23,000 in 2013, $21,000 in 2014 and $18,000 in
2015.
7
Note 5 Product Warranties
In the ordinary course of business, we warrant our products against defects in design, materials
and workmanship typically over periods ranging from twelve to thirty-six months. We determine
warranty reserves needed by product line based on historical experience and current facts and
circumstances. Activity in the warranty accrual is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
April 2, |
|
April 3, |
|
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
Warranty accrual at beginning of period |
|
$ |
16,305 |
|
|
$ |
13,749 |
|
|
$ |
14,856 |
|
|
$ |
14,675 |
|
Warranties issued during current period |
|
|
3,597 |
|
|
|
1,693 |
|
|
|
6,746 |
|
|
|
3,427 |
|
Adjustments to pre-existing warranties |
|
|
397 |
|
|
|
(3 |
) |
|
|
390 |
|
|
|
(101 |
) |
Reductions for settling warranties |
|
|
(2,063 |
) |
|
|
(913 |
) |
|
|
(3,643 |
) |
|
|
(3,425 |
) |
Foreign currency translation |
|
|
334 |
|
|
|
(344 |
) |
|
|
221 |
|
|
|
(394 |
) |
|
Warranty accrual at end of period |
|
$ |
18,570 |
|
|
$ |
14,182 |
|
|
$ |
18,570 |
|
|
$ |
14,182 |
|
|
Note 6 Derivative Financial Instruments
We principally use derivative financial instruments to manage interest rate risk associated with
long-term debt and foreign exchange risk related to foreign operations and foreign currency
transactions. We enter into derivative financial instruments with a number of major financial
institutions to minimize counterparty credit risk.
Derivatives designated as hedging instruments
Interest rate swaps are used to adjust the proportion of total debt that is subject to variable and
fixed interest rates. The interest rate swaps are designated as hedges of the amount of future cash
flows related to interest payments on variable-rate debt that, in combination with the interest
payments on the debt, convert a portion of the variable-rate debt to fixed-rate debt. At April 2,
2011, we had interest rate swaps with notional amounts totaling $50,000. The interest rate swaps
effectively convert this amount of variable-rate debt to fixed-rate debt at 2.9%, including the
applicable margin of 175 basis points as of April 2, 2011. The interest will revert back to
variable rates based on LIBOR plus the applicable margin upon the maturity of the interest rate
swaps in 2012.
We use foreign currency forward contracts as cash flow hedges to effectively fix the exchange rates
on future payments. To mitigate exposure in movements between various currencies, primarily the
Philippine peso, we had outstanding foreign currency forwards with notional amounts of $20,223 at
April 2, 2011. These contracts mature at various times through the first quarter of 2012.
These interest rate swaps and foreign currency forwards are recorded in the consolidated balance
sheet at fair value and the related gains or losses are deferred in shareholders equity as a
component of Accumulated Other Comprehensive Income (Loss) (AOCI). These deferred gains and losses
are reclassified into expense during the periods in which the related payments or receipts affect
earnings. However, to the extent the interest rate swaps and foreign currency forwards are not
perfectly effective in offsetting the change in the value of the payments being hedged, the
ineffective portion of these contracts is recognized in earnings immediately. Ineffectiveness was
not material in 2011 or 2010.
8
Activity in AOCI related to these derivatives is summarized below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
April 2, |
|
April 3, |
|
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
Balance at beginning of period |
|
$ |
186 |
|
|
$ |
577 |
|
|
$ |
144 |
|
|
$ |
(189 |
) |
Net (decrease) increase in fair value of derivatives, net of tax
of $61, $350, ($15) and ($51), respectively |
|
|
(97 |
) |
|
|
(817 |
) |
|
|
30 |
|
|
|
65 |
|
Net reclassification from AOCI into earnings, net of tax of $49, ($5),
$91 and $11, respectively |
|
|
(79 |
) |
|
|
39 |
|
|
|
(164 |
) |
|
|
(77 |
) |
|
Balance at end of period |
|
$ |
10 |
|
|
$ |
(201 |
) |
|
$ |
10 |
|
|
$ |
(201 |
) |
|
Activity and classification of derivatives are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net reclassification from AOCI into earnings |
|
Net deferral in AOCI of derivatives |
|
|
|
|
|
|
(effective portion) |
|
(effective portion) |
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
Three Months Ended |
|
Six Months Ended |
|
|
Statement of earnings |
|
April 2, |
|
April 3, |
|
April 2, |
|
April 3, |
|
April 2, |
|
April 3, |
|
April 2, |
|
April 3, |
|
|
classification |
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
Interest rate swaps |
|
Interest expense |
|
$ |
(105 |
) |
|
$ |
(106 |
) |
|
$ |
(210 |
) |
|
$ |
(433 |
) |
|
$ |
(30 |
) |
|
$ |
(454 |
) |
|
$ |
(58 |
) |
|
$ |
(293 |
) |
Foreign currency forwards |
|
Cost of sales |
|
|
233 |
|
|
|
62 |
|
|
|
465 |
|
|
|
521 |
|
|
|
(128 |
) |
|
|
(713 |
) |
|
|
103 |
|
|
|
409 |
|
|
Net gain (loss) |
|
|
|
|
|
$ |
128 |
|
|
$ |
(44 |
) |
|
$ |
255 |
|
|
$ |
88 |
|
|
$ |
(158 |
) |
|
$ |
(1,167 |
) |
|
$ |
45 |
|
|
$ |
116 |
|
|
Derivatives not designated as hedging instruments
We also have foreign currency exposure on intercompany balances that are denominated in a foreign
currency and are adjusted to current values using period-end exchange rates. The resulting gains or
losses are recorded in the statements of earnings. To minimize foreign currency exposure, we had
foreign currency forwards with notional amounts of $155,078 at April 2, 2011. The foreign currency
forwards are recorded in the consolidated balance sheet at fair value and resulting gains or losses
are recorded in the statements of earnings. We recorded the following gains and losses on foreign
currency forwards which are included in other income or expense and generally offset the gains or
losses from the foreign currency adjustments on the intercompany balances:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
April 2, |
|
April 3, |
|
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
Net gain (loss)
|
|
$ |
1,648 |
|
|
$ |
(932 |
) |
|
$ |
(675 |
) |
|
$ |
(3,504 |
) |
|
9
Summary of derivatives
The fair value and classification of derivatives on the consolidated balance sheets are
summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
April 2, |
|
October 2, |
|
|
|
|
|
|
2011 |
|
2010 |
|
Derivatives designated as hedging instruments: |
|
|
|
|
|
|
|
|
Foreign currency forwards |
|
Other current assets |
|
$ |
384 |
|
|
$ |
498 |
|
Foreign currency forwards |
|
Other assets |
|
|
|
|
|
|
92 |
|
|
|
|
|
|
|
|
$ |
384 |
|
|
$ |
590 |
|
|
Foreign currency forwards |
|
Other accrued liabilities |
|
$ |
59 |
|
|
$ |
|
|
Foreign currency forwards |
|
Other long-term liabilities |
|
|
80 |
|
|
|
|
|
Interest rate swaps |
|
Other accrued liabilities |
|
|
292 |
|
|
|
381 |
|
Interest rate swaps |
|
Other long-term liabilities |
|
|
|
|
|
|
63 |
|
|
|
|
|
|
|
|
$ |
431 |
|
|
$ |
444 |
|
|
Derivatives not designated as hedging instruments: |
|
|
|
|
|
|
|
|
Foreign currency forwards |
|
Other current assets |
|
$ |
2,664 |
|
|
$ |
3,101 |
|
Foreign currency forwards |
|
Other assets |
|
|
|
|
|
|
74 |
|
|
|
|
|
|
|
|
$ |
2,664 |
|
|
$ |
3,175 |
|
|
Foreign currency forwards |
|
Other accrued liabilities |
|
$ |
2,206 |
|
|
$ |
2,346 |
|
Foreign currency forwards |
|
Other long-term liabilities |
|
|
|
|
|
|
61 |
|
|
|
|
|
|
|
|
$ |
2,206 |
|
|
$ |
2,407 |
|
|
Note 7 Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants at the measurement date. Depending
on the nature of the asset or liability, various techniques and assumptions can be used to estimate
fair value. The definition of the fair value hierarchy is as follows:
Level 1 Quoted prices in active markets for identical assets and liabilities.
Level 2 Observable inputs other than quoted prices in active markets for similar assets and
liabilities.
Level 3 Inputs for which significant valuation assumptions are unobservable in a market and
therefore value is based on the best available data, some of which is internally developed and
considers risk premiums that a market participant would require.
Our derivatives are valued using various pricing models or discounted cash flow analyses that
incorporate observable market data, such as interest rate yield curves and currency rates,
classified as Level 2 within the valuation hierarchy. Our Level 3 fair value liabilities represent
contingent consideration recorded for acquisitions to be paid if various financial targets are met.
The amounts recorded were calculated for each payment scenario in each period using an estimate of
the probability of the future cash outflows. The varying contingent payments were then discounted
to the present value at the weighted average cost of capital.
10
The following table presents the fair values and classification of our financial assets and
liabilities measured on a recurring basis as of April 2, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Classification |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
Foreign currency forwards |
|
Other current assets |
|
$ |
|
|
|
$ |
3,048 |
|
|
$ |
|
|
|
$ |
3,048 |
|
|
|
|
|
|
|
|
$ |
|
|
|
$ |
3,048 |
|
|
$ |
|
|
|
$ |
3,048 |
|
|
Foreign currency forwards |
|
Other accrued liabilities |
|
$ |
|
|
|
$ |
2,265 |
|
|
$ |
|
|
|
$ |
2,265 |
|
Foreign currency forwards |
|
Other long-term liabilities |
|
|
|
|
|
|
80 |
|
|
|
|
|
|
|
80 |
|
Interest rate swaps |
|
Other accrued liabilities |
|
|
|
|
|
|
292 |
|
|
|
|
|
|
|
292 |
|
Acquisition contingent consideration |
|
Other accrued liabilities |
|
|
|
|
|
|
|
|
|
|
300 |
|
|
|
300 |
|
Acquisition contingent consideration |
|
Other long-term liabilities |
|
|
|
|
|
|
|
|
|
|
2,116 |
|
|
|
2,116 |
|
|
|
|
|
|
|
|
$ |
|
|
|
$ |
2,637 |
|
|
$ |
2,416 |
|
|
$ |
5,053 |
|
|
During 2010, we recorded contingent purchase price consideration for acquisitions. As of
October 2, 2010, the fair value of those liabilities was $3,112. The change in the fair value for
the six months ended April 2, 2011 represents an increase of $299 in the discounted future cash
flows and is recorded as a component of interest expense and reductions of $995 due to earn out
provisions not being achieved and are recorded as other income.
Our only financial instrument for which the carrying value differs from its fair value is long-term
debt. At April 2, 2011, the fair value of long-term debt was $732,929 compared to its carrying
value of $718,437. The fair value of long-term debt was estimated based on quoted market prices.
Note 8 Restructuring
In 2009, we initiated restructuring plans to better align our cost structure with lower sales
activity associated with the global recession. The restructuring actions taken have resulted in
workforce reductions, primarily in the U.S., the Philippines and Europe.
Restructuring expense by segment related to severance is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
April 2, |
|
April 3, |
|
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
Aircraft Controls |
|
$ |
43 |
|
|
$ |
971 |
|
|
$ |
43 |
|
|
$ |
2,163 |
|
Space and Defense Controls |
|
|
65 |
|
|
|
|
|
|
|
65 |
|
|
|
|
|
Industrial Systems |
|
|
395 |
|
|
|
87 |
|
|
|
453 |
|
|
|
481 |
|
Components |
|
|
15 |
|
|
|
179 |
|
|
|
15 |
|
|
|
418 |
|
Medical Devices |
|
|
|
|
|
|
83 |
|
|
|
|
|
|
|
77 |
|
|
Total |
|
$ |
518 |
|
|
$ |
1,320 |
|
|
$ |
576 |
|
|
$ |
3,139 |
|
|
We do not anticipate significant additional amounts for the remainder of 2011. Payments related
to these severance benefits are expected to be paid in full by the end of 2011.
11
Restructuring activity for the six months ended April 2, 2011 is as follows:
|
|
|
|
|
|
|
Severance |
|
Restructuring accrual at beginning of period |
|
$ |
3,389 |
|
Restructuring charges |
|
|
684 |
|
Expense adjustments for prior year accruals |
|
|
(108 |
) |
Cash payments |
|
|
(2,914 |
) |
Foreign currency translation |
|
|
16 |
|
|
Restructuring accrual at end of period |
|
$ |
1,067 |
|
|
Note 9 Employee Benefit Plans
Net periodic benefit costs for U.S. pension plans consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
April 2, |
|
April 3, |
|
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
Service cost |
|
$ |
5,642 |
|
|
$ |
4,679 |
|
|
$ |
11,284 |
|
|
$ |
9,359 |
|
Interest cost |
|
|
7,171 |
|
|
|
6,766 |
|
|
|
14,342 |
|
|
|
13,533 |
|
Expected return on plan assets |
|
|
(9,772 |
) |
|
|
(8,836 |
) |
|
|
(19,544 |
) |
|
|
(17,672 |
) |
Amortization of prior service cost |
|
|
2 |
|
|
|
51 |
|
|
|
4 |
|
|
|
101 |
|
Amortization of actuarial loss |
|
|
2,823 |
|
|
|
1,238 |
|
|
|
5,646 |
|
|
|
2,475 |
|
|
Pension expense for defined benefit plans |
|
|
5,866 |
|
|
|
3,898 |
|
|
|
11,732 |
|
|
|
7,796 |
|
Pension expense for defined contribution plans |
|
|
1,678 |
|
|
|
1,745 |
|
|
|
3,225 |
|
|
|
3,473 |
|
|
Total pension expense for U.S. plans |
|
$ |
7,544 |
|
|
$ |
5,643 |
|
|
$ |
14,957 |
|
|
$ |
11,269 |
|
|
Net periodic benefit costs for non-U.S. pension plans consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
April 2, |
|
April 3, |
|
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
Service cost |
|
$ |
1,188 |
|
|
$ |
786 |
|
|
$ |
2,360 |
|
|
$ |
1,604 |
|
Interest cost |
|
|
1,553 |
|
|
|
1,479 |
|
|
|
3,079 |
|
|
|
3,042 |
|
Expected return on plan assets |
|
|
(971 |
) |
|
|
(902 |
) |
|
|
(1,925 |
) |
|
|
(1,846 |
) |
Amortization of prior service credit |
|
|
(14 |
) |
|
|
(13 |
) |
|
|
(28 |
) |
|
|
(27 |
) |
Amortization of actuarial loss |
|
|
385 |
|
|
|
128 |
|
|
|
763 |
|
|
|
261 |
|
|
Pension expense for defined benefit plans |
|
|
2,141 |
|
|
|
1,478 |
|
|
|
4,249 |
|
|
|
3,034 |
|
Pension expense for defined contribution plans |
|
|
1,102 |
|
|
|
1,449 |
|
|
|
2,249 |
|
|
|
2,879 |
|
|
Total pension expense for non-U.S. plans |
|
$ |
3,243 |
|
|
$ |
2,927 |
|
|
$ |
6,498 |
|
|
$ |
5,913 |
|
|
12
Net periodic benefit costs for the post-retirement health care benefit plan consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
April 2, |
|
April 3, |
|
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
Service cost |
|
$ |
122 |
|
|
$ |
143 |
|
|
$ |
245 |
|
|
$ |
286 |
|
Interest cost |
|
|
275 |
|
|
|
336 |
|
|
|
551 |
|
|
|
672 |
|
Amortization of transition obligation |
|
|
99 |
|
|
|
99 |
|
|
|
198 |
|
|
|
198 |
|
Amortization of prior service cost |
|
|
|
|
|
|
54 |
|
|
|
|
|
|
|
108 |
|
Amortization of actuarial loss |
|
|
149 |
|
|
|
210 |
|
|
|
298 |
|
|
|
420 |
|
|
Total periodic post-retirement benefit cost |
|
$ |
645 |
|
|
$ |
842 |
|
|
$ |
1,292 |
|
|
$ |
1,684 |
|
|
Actual contributions for the six months ended April 2, 2011 and anticipated additional 2011
contributions to our defined benefit pension are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Plans |
|
Non-U.S. Plans |
|
Total |
|
Actual |
|
$ |
15,414 |
|
|
$ |
4,432 |
|
|
$ |
19,846 |
|
Anticipated |
|
|
16,270 |
|
|
|
2,548 |
|
|
|
18,818 |
|
|
|
|
$ |
31,684 |
|
|
$ |
6,980 |
|
|
$ |
38,664 |
|
|
Note 10 Income Taxes
The effective tax rates of 29.3% and 28.1% for the three and six months ended April 2, 2011 and
29.6% and 28.3% for the three and six months ended April 3, 2010 are lower than would be expected
by applying the U.S. federal statutory tax rate to earnings before income taxes primarily as a
result of a significant portion of our earnings that come from foreign operations with lower tax
rates.
13
Note 11 Shareholders Equity
The changes in shareholders equity for the six months ended April 2, 2011 are summarized as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
|
|
|
|
|
Class A |
|
Class B |
|
|
|
|
|
|
Common |
|
Common |
|
|
Amount |
|
Stock |
|
Stock |
|
COMMON STOCK |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
$ |
51,280 |
|
|
|
43,485,417 |
|
|
|
7,794,296 |
|
Conversion of Class B to Class A |
|
|
|
|
|
|
34,660 |
|
|
|
(34,660 |
) |
|
|
|
End of Period |
|
|
51,280 |
|
|
|
43,520,077 |
|
|
|
7,759,636 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ADDITIONAL PAID-IN CAPITAL |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
|
389,376 |
|
|
|
|
|
|
|
|
|
Equity-based compensation expense |
|
|
5,175 |
|
|
|
|
|
|
|
|
|
Issuance of treasury shares at more than cost |
|
|
893 |
|
|
|
|
|
|
|
|
|
Income tax effect of equity-based compensation |
|
|
99 |
|
|
|
|
|
|
|
|
|
Adjustment to market SECT |
|
|
3,985 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
End of period |
|
|
399,528 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RETAINED EARNINGS |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
|
880,733 |
|
|
|
|
|
|
|
|
|
Net earnings |
|
|
64,022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
End of period |
|
|
944,755 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TREASURY STOCK |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
|
(47,724 |
) |
|
|
(2,221,635 |
) |
|
|
(3,305,971 |
) |
Issuance of treasury shares |
|
|
774 |
|
|
|
145,193 |
|
|
|
|
|
Purchase of treasury shares |
|
|
(1,192 |
) |
|
|
(28,015 |
) |
|
|
|
|
|
|
|
End of period |
|
|
(48,142 |
) |
|
|
(2,104,457 |
) |
|
|
(3,305,971 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
STOCK EMPLOYEE COMPENSATION TRUST (SECT) |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
|
(13,381 |
) |
|
|
|
|
|
|
(374,502 |
) |
Issuance of shares |
|
|
525 |
|
|
|
|
|
|
|
11,759 |
|
Purchase of shares |
|
|
(3,856 |
) |
|
|
|
|
|
|
(91,139 |
) |
Adjustment to market SECT |
|
|
(3,985 |
) |
|
|
|
|
|
|
|
|
|
|
|
End of period |
|
|
(20,697 |
) |
|
|
|
|
|
|
(453,882 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
|
(139,328 |
) |
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
|
|
15,725 |
|
|
|
|
|
|
|
|
|
Retirement liability adjustment |
|
|
3,965 |
|
|
|
|
|
|
|
|
|
Decrease in accumulated income on derivatives |
|
|
(134 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
End of period |
|
|
(119,772 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHAREHOLDERS EQUITY |
|
$ |
1,206,952 |
|
|
|
41,415,620 |
|
|
|
3,999,783 |
|
|
|
|
14
Note 12 Stock Employee Compensation Trust
The Stock Employee Compensation Trust (SECT) assists in administering and provides funding for
equity-based compensation plans and benefit programs, including the Moog Inc. Retirement Savings
Plan. The shares in the SECT are not considered outstanding for purposes of calculating earnings
per share. However, in accordance with the trust agreement governing the SECT, the SECT trustee
votes all shares held by the SECT on all matters submitted to shareholders.
Note 13 Earnings per Share
Basic and diluted weighted-average shares outstanding are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
April 2, |
|
April 3, |
|
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
Weighted-average shares outstanding Basic |
|
|
45,419,121 |
|
|
|
45,374,912 |
|
|
|
45,404,006 |
|
|
|
45,349,131 |
|
Dilutive effect of equity-based awards |
|
|
639,870 |
|
|
|
355,340 |
|
|
|
578,766 |
|
|
|
312,433 |
|
|
Weighted-average shares outstanding Diluted |
|
|
46,058,991 |
|
|
|
45,730,252 |
|
|
|
45,982,772 |
|
|
|
45,661,564 |
|
|
Note 14 Comprehensive Income
The components of comprehensive income, net of tax, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
April 2, |
|
April 3, |
|
|
2011 |
|
2010 |
|
2011 |
|
2010 |
|
Net earnings |
|
$ |
30,615 |
|
|
$ |
25,001 |
|
|
$ |
64,022 |
|
|
$ |
46,562 |
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
|
|
21,040 |
|
|
|
(12,396 |
) |
|
|
15,725 |
|
|
|
(13,822 |
) |
Retirement liability adjustment, net of tax of $1,264, $660,
$2,526 and $1,321, respectively |
|
|
1,787 |
|
|
|
707 |
|
|
|
3,965 |
|
|
|
1,682 |
|
Decrease in accumulated income or loss on derivatives |
|
|
(176 |
) |
|
|
(778 |
) |
|
|
(134 |
) |
|
|
(12 |
) |
|
Comprehensive income |
|
$ |
53,266 |
|
|
$ |
12,534 |
|
|
$ |
83,578 |
|
|
$ |
34,410 |
|
|
The components of accumulated other comprehensive income (loss), net of tax, are as follows:
|
|
|
|
|
|
|
|
|
|
|
April 2, |
|
|
October 2, |
|
|
|
2011 |
|
|
2010 |
|
|
Cumulative foreign currency translation adjustment |
|
$ |
58,589 |
|
|
$ |
42,864 |
|
Accumulated retirement liability adjustments |
|
|
(178,371 |
) |
|
|
(182,336 |
) |
Accumulated income on derivatives |
|
|
10 |
|
|
|
144 |
|
|
Accumulated other comprehensive loss |
|
$ |
(119,772 |
) |
|
$ |
(139,328 |
) |
|
15
Note 15 Segment Information
Below are sales and operating profit by segment for the three and six months ended April 2, 2011
and April 3, 2010 and a reconciliation of segment operating profit to earnings before income taxes.
Operating profit is net sales less cost of sales and other operating expenses, excluding interest
expense, equity-based compensation expense and other corporate expenses. Cost of sales and other
operating expenses are directly identifiable to the respective segment or allocated on the basis of
sales, number of employees or profit.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
April 2, |
|
|
April 3, |
|
|
April 2, |
|
|
April 3, |
|
|
|
2011 |
|
|
2010 |
|
|
2011 |
|
|
2010 |
|
|
Net sales: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aircraft Controls |
|
$ |
206,030 |
|
|
$ |
188,753 |
|
|
$ |
401,981 |
|
|
$ |
363,813 |
|
Space and Defense Controls |
|
|
87,791 |
|
|
|
79,084 |
|
|
|
183,537 |
|
|
|
148,575 |
|
Industrial Systems |
|
|
155,851 |
|
|
|
120,441 |
|
|
|
299,596 |
|
|
|
256,793 |
|
Components |
|
|
90,348 |
|
|
|
89,839 |
|
|
|
176,699 |
|
|
|
174,745 |
|
Medical Devices |
|
|
34,206 |
|
|
|
32,371 |
|
|
|
66,847 |
|
|
|
61,740 |
|
|
Net sales |
|
$ |
574,226 |
|
|
$ |
510,488 |
|
|
$ |
1,128,660 |
|
|
$ |
1,005,666 |
|
|
Operating profit (loss) and margins: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aircraft Controls |
|
$ |
19,168 |
|
|
$ |
19,575 |
|
|
$ |
39,363 |
|
|
$ |
37,185 |
|
|
|
|
9.3 |
% |
|
|
10.4 |
% |
|
|
9.8 |
% |
|
|
10.2 |
% |
Space and Defense Controls |
|
|
13,083 |
|
|
|
8,678 |
|
|
|
28,898 |
|
|
|
16,197 |
|
|
|
|
14.9 |
% |
|
|
11.0 |
% |
|
|
15.7 |
% |
|
|
10.9 |
% |
Industrial Systems |
|
|
15,858 |
|
|
|
8,139 |
|
|
|
30,265 |
|
|
|
19,320 |
|
|
|
|
10.2 |
% |
|
|
6.8 |
% |
|
|
10.1 |
% |
|
|
7.5 |
% |
Components |
|
|
13,255 |
|
|
|
14,396 |
|
|
|
28,058 |
|
|
|
26,518 |
|
|
|
|
14.7 |
% |
|
|
16.0 |
% |
|
|
15.9 |
% |
|
|
15.2 |
% |
Medical Devices |
|
|
(1,504 |
) |
|
|
12 |
|
|
|
(2,995 |
) |
|
|
151 |
|
|
|
|
(4.4 |
%) |
|
|
0.0 |
% |
|
|
(4.5 |
%) |
|
|
0.2 |
% |
|
Total operating profit |
|
|
59,860 |
|
|
|
50,800 |
|
|
|
123,589 |
|
|
|
99,371 |
|
|
|
|
10.4 |
% |
|
|
10.0 |
% |
|
|
11.0 |
% |
|
|
9.9 |
% |
Deductions from operating profit: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
8,970 |
|
|
|
9,248 |
|
|
|
18,181 |
|
|
|
19,976 |
|
Equity-based compensation expense |
|
|
1,742 |
|
|
|
894 |
|
|
|
5,175 |
|
|
|
3,678 |
|
Corporate expenses and other |
|
|
5,843 |
|
|
|
5,163 |
|
|
|
11,148 |
|
|
|
10,770 |
|
|
Earnings before income taxes |
|
$ |
43,305 |
|
|
$ |
35,495 |
|
|
$ |
89,085 |
|
|
$ |
64,947 |
|
|
16
Note 16 Recent Accounting Pronouncements
In June 2009, the Financial Accounting Standards Board (FASB) issued new standards on consolidation
as codified in Accounting Standards Codification (ASC) 810-10. The new standard amends the
consolidation guidance applicable to variable interest entities and affects the overall
consolidation analysis. The new standard is effective for fiscal years beginning after November 15,
2009. We adopted this standard at the beginning of 2011. The adoption of this standard did not have
a material impact on our consolidated financial statements.
In October 2009, the FASB issued new standards for allocating revenue to multiple deliverables in a
contract as codified in ASC 605-25. The new standard allows entities to allocate consideration in a
multiple element arrangement in a manner that better reflects the transaction economics. When
vendor specific objective evidence or third party evidence for deliverables in an arrangement
cannot be determined, entities will be allowed to develop their best estimate of the selling price
for each deliverable and allocate arrangement consideration using the relative selling price
method. Additionally, use of the residual method has been eliminated. We adopted this standard at
the beginning of 2011. The adoption of this standard did not have a material impact on our
consolidated financial statements.
In January 2010, the FASB issued Accounting Standards Update (ASU) No. 2010-06, Fair Value
Measurements and Disclosures (ASC Topic 820) Improving Disclosures About Fair Value
Measurements. This amendment requires new disclosures about transfers into and out of Levels 1 and
2 and separate disclosures about purchases, sales, issuances and settlements relating to Level 3
measurements. It also clarifies existing fair value disclosures about the level of disaggregation
and about inputs and valuation techniques used to measure fair value. The new disclosures and
clarifications of existing disclosures are effective for interim and annual reporting periods
beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances and
settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures
are effective for fiscal years beginning after December 15, 2010 and for interim periods within
those fiscal years. This standard is effective for us beginning in the second quarter of 2010 for
Level 1 and 2 disclosures and in the first quarter of 2012 for Level 3 disclosures. Other than
requiring additional disclosures, the adoption of this new guidance will not have a material impact
on our consolidated financial statements.
In April 2010, the FASB issued ASU 2010-17, Milestone Method of Revenue Recognition. This ASU
allows entities to make a policy election to use the milestone method of revenue recognition and
provides guidance on defining a milestone and the criteria that should be met to applying the
milestone method. The scope of this ASU is limited to the transactions involving milestones related
to research and development deliverables. We adopted this standard at the beginning of 2011. The
adoption of this standard did not have a material impact on our consolidated financial statements.
In July 2010, the FASB issued new disclosure requirements about the credit quality of financing
receivables and allowance for credit losses, as codified in ASC 310. The objective of the new
standard is to facilitate financial statement users evaluation of the nature of the credit risk
inherent in an entitys portfolio, how that risk is analyzed and assessed in arriving at the
allowance for credit losses and explanations for changes in the allowance for credit losses. In
addition, the amendment requires entities to disclose credit quality indicators, past due
information and modification to financing receivables. The new standard is effective for interim
and annual periods ending on or after December 15, 2010. We adopted this standard at the beginning
of 2011. The adoption of this standard did not have a material impact on our consolidated financial
statements.
17
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations.
The following should be read in conjunction with Managements Discussion and Analysis of Financial
Condition and Results of Operations contained in the Companys Form 10-K for the fiscal year ended
October 2, 2010. All references to years in this Managements Discussion and Analysis of Financial
Condition and Results of Operations are to fiscal years.
OVERVIEW
We are a worldwide designer, manufacturer and integrator of high performance precision motion and
fluid controls and control systems for a broad range of applications in aerospace and defense,
industrial and medical markets. Our aerospace and defense products and systems include military and
commercial aircraft flight controls, satellite positioning controls, controls for steering tactical
and strategic missiles, thrust vector controls for space launch vehicles, controls for gun aiming,
stabilization and automatic ammunition loading for armored combat vehicles, and security and
surveillance products. Our industrial products are used in a wide range of applications, including
injection molding machines, pilot training simulators, wind energy, power generation, material and
automotive testing, metal forming, heavy industry and oil exploration. Our medical products include
infusion therapy pumps, enteral clinical nutrition pumps, slip rings used on CT scanners and motors
used in sleep apnea devices. We operate under five segments, Aircraft Controls, Space and Defense
Controls, Industrial Systems, Components and Medical Devices. Our principal manufacturing
facilities are located in the United States, including facilities in New York, California, Utah,
Virginia, North Carolina, Pennsylvania, Ohio, Georgia and Illinois, and in England, Germany, Italy,
Japan, the Philippines, Ireland, India and China.
We have long-term contracts with some of our customers. These contracts are predominantly within
Aircraft Controls and Space and Defense Controls and represent approximately one-third of our
sales. We recognize revenue on these contracts using the percentage of completion, cost-to-cost
method of accounting as work progresses toward completion. The remainder of our sales are
recognized when the risks and rewards of ownership and title to the product are transferred to the
customer, principally as units are delivered or as service obligations are satisfied. This method
of revenue recognition is predominantly used within the Industrial Systems, Components and Medical
Devices segments, as well as with aftermarket activity.
We concentrate on providing our customers with products designed and manufactured to the highest
quality standards. In achieving a leadership position in the high performance, precision controls
market, we have capitalized on our strengths, which include:
|
|
|
superior technical competence and customer intimacy breeding market leadership, |
|
|
|
|
customer diversity and broad product portfolio, |
|
|
|
|
well-established international presence serving customers worldwide, and |
|
|
|
|
proven ability to successfully integrate acquisitions. |
We intend to increase our revenue base and improve our profitability and cash flows from operations
by building on our market leadership positions, by strengthening our niche market positions in the
principal markets we serve and by extending our participation on the platforms we supply by
providing more systems solutions. We also expect to maintain a balanced, diversified portfolio in
terms of markets served, product applications, customer base and geographic presence. Our strategy
to achieve our objectives includes:
|
|
|
maintaining our technological excellence by building upon our systems integration
capabilities while solving our customers most demanding technical problems, |
|
|
|
|
taking advantage of our global capabilities, |
|
|
|
|
growing our profitable aftermarket business, |
|
|
|
|
capitalizing on strategic acquisitions and opportunities, |
|
|
|
|
entering and developing new markets, and |
|
|
|
|
striving for continuing cost improvements. |
Challenges facing us include improving shareholder value through increased profitability while
experiencing pricing pressures from customers, strong competition, increases in costs such as
retirement and health care benefits and adjusting to global economic conditions. We address these
challenges by focusing on strategic revenue growth and by continuing to improve operating
efficiencies through various process, manufacturing and restructuring initiatives and using low
cost manufacturing facilities without compromising quality.
18
Acquisitions
All of our acquisitions are accounted for under the purchase method and, accordingly, the operating
results for the acquired companies are included in the consolidated statements of earnings from the
respective dates of acquisition. Under purchase accounting, we record assets and liabilities at
fair value on the balance sheet. The purchase price described for each acquisition below is net of
any cash acquired and includes debt issued or assumed.
During the six months ended April 2, 2011, we completed one business combination within our
Aircraft Controls segment for a purchase price of $3 million. This acquisition complements our
military aftermarket business.
In 2010, we completed four business combinations within three of our segments. We completed one
acquisition in our Aircraft Controls segment for $11 million. This acquisition complements our
military aftermarket business. We completed two acquisitions in our Space and Defense Controls
segment for a total of $23 million. One business specializes in turret design, fire control systems
and vehicle electronics and the other expands our capabilities in the security and surveillance
market. We completed one acquisition in our Industrial Systems segment for $1 million.
CRITICAL ACCOUNTING POLICIES
There have been no changes in critical accounting policies in the current year from those disclosed
in our 2010 Form 10-K.
Reviews for Impairment of Goodwill
Our most recent test of goodwill for impairment was our annual test as of the beginning of our
fourth quarter in 2010. The results of that test indicated that goodwill was not impaired and the
fair value of each reporting unit exceeded its carrying value by over 10%.
The most significant assumptions in determining fair value are projected revenue growth rates,
operating profit margins and cash flows, the terminal growth rate and the discount rate. Management
projects revenue growth rates, operating margins and cash flows based on each reporting units
current business, expected developments and operational strategies over a five-year period. In
estimating the terminal growth rate, we consider our historical and projected results, as well as
the economic environment in which our reporting units operate. Significant program delays, changes
in demand due to economic pressures or unfavorable terms in our contracts could have a negative
effect on the fair value of a reporting unit.
19
RECENT ACCOUNTING PRONOUNCEMENTS
In January 2010, the FASB issued ASU No. 2010-06, Fair Value Measurements and Disclosures (ASC
Topic 820) Improving Disclosures About Fair Value Measurements. This amendment requires new
disclosures about transfers into and out of Levels 1 and 2 and separate disclosures about
purchases, sales, issuances and settlements relating to Level 3 measurements. It also clarifies
existing fair value disclosures about the level of disaggregation and about inputs and valuation
techniques used to measure fair value. The new disclosures and clarifications of existing
disclosures are effective for interim and annual reporting periods beginning after December 15,
2009, except for the disclosures about purchases, sales, issuances and settlements in the roll
forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal
years beginning after December 15, 2010 and for interim periods within those fiscal years. This
standard is effective for us beginning in the second quarter of 2010 for Level 1 and 2 disclosures
and in the first quarter of 2012 for Level 3 disclosures. Other than requiring additional
disclosures, the adoption of this new guidance will not have a material impact on our consolidated
financial statements.
In December 2010, the FASB issued ASU No. 2010-28, Intangibles-Goodwill and Other (ASC Topic 350)
When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative
Carrying Amounts. This amendment modifies the criteria for performing Step 2 of the goodwill
impairment test for reporting units with zero or negative carrying amounts, and it requires
performing Step 2 if qualitative factors indicate that it is more likely than not that an
impairment exists. The new standard is effective for fiscal years, and interim periods within
those years, beginning after December 15, 2010. Any goodwill impairment resulting from the initial
adoption of the amendments should be recorded as a cumulative effect adjustment to beginning
retained earnings. Any goodwill impairments occurring after the initial adoption of the amendments
should be included in earnings. We will adopt this standard in the first quarter of 2012. We do
not expect the adoption of this standard will have a material impact on our consolidated financial
statements.
In December 2010, the FASB issued ASU No. 2010-29, Business Combinations (ASC Topic 805)
Disclosure of Supplementary Pro Forma Information for Business Combinations. This amendment
expands the supplemental pro forma disclosures to include a description of the nature and amount of
material, nonrecurring pro forma adjustments directly attributable to the business combination
included in the reported pro forma revenue and earnings. This amendment is effective prospectively
for business combinations for which the acquisition date is on or after the beginning of the first
annual reporting period beginning on or after December 15, 2010. Early adoption is permitted. We
will adopt this standard at the beginning of 2012. Other than requiring additional disclosures,
the adoption of this amendment will not have a material impact on our consolidated financial
statements.
20
CONSOLIDATED RESULTS OF OPERATIONS AND OUTLOOK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
$ |
|
% |
|
April 2, |
|
April 3, |
|
$ |
|
% |
(dollars in millions, except per share data) |
|
2011 |
|
2010 |
|
Variance |
|
Variance |
|
2011 |
|
2010 |
|
Variance |
|
Variance |
|
Net sales |
|
$ |
574.2 |
|
|
$ |
510.5 |
|
|
$ |
63.7 |
|
|
|
12 |
% |
|
$ |
1,128.7 |
|
|
$ |
1,005.7 |
|
|
$ |
123.0 |
|
|
|
12 |
% |
Gross margin |
|
|
29.1 |
% |
|
|
29.0 |
% |
|
|
|
|
|
|
|
|
|
|
29.4 |
% |
|
|
29.1 |
% |
|
|
|
|
|
|
|
|
Research and development expenses |
|
$ |
28.2 |
|
|
$ |
25.5 |
|
|
$ |
2.7 |
|
|
|
11 |
% |
|
$ |
51.6 |
|
|
$ |
49.4 |
|
|
$ |
2.2 |
|
|
|
4 |
% |
Selling, general and administrative expenses
as a percentage of sales |
|
|
15.1 |
% |
|
|
14.9 |
% |
|
|
|
|
|
|
|
|
|
|
15.3 |
% |
|
|
15.3 |
% |
|
|
|
|
|
|
|
|
Restructuring expense |
|
$ |
0.5 |
|
|
$ |
1.3 |
|
|
$ |
(0.8 |
) |
|
|
(62 |
%) |
|
$ |
0.6 |
|
|
$ |
3.1 |
|
|
$ |
(2.5 |
) |
|
|
(81 |
%) |
Interest expense |
|
$ |
9.0 |
|
|
$ |
9.2 |
|
|
$ |
(0.2 |
) |
|
|
(2 |
%) |
|
$ |
18.2 |
|
|
$ |
20.0 |
|
|
$ |
(1.8 |
) |
|
|
(9 |
%) |
Effective tax rate |
|
|
29.3 |
% |
|
|
29.6 |
% |
|
|
|
|
|
|
|
|
|
|
28.1 |
% |
|
|
28.3 |
% |
|
|
|
|
|
|
|
|
Net earnings |
|
$ |
30.6 |
|
|
$ |
25.0 |
|
|
$ |
5.6 |
|
|
|
22 |
% |
|
$ |
64.0 |
|
|
$ |
46.6 |
|
|
$ |
17.4 |
|
|
|
37 |
% |
Diluted earnings per share |
|
$ |
0.66 |
|
|
$ |
0.55 |
|
|
$ |
0.11 |
|
|
|
20 |
% |
|
$ |
1.39 |
|
|
$ |
1.02 |
|
|
$ |
0.37 |
|
|
|
36 |
% |
Net sales increased in the second quarter of 2011 compared to 2010 in all of our segments with
the largest increases coming from Industrial Systems and Aircraft Controls.
Net sales also increased in the first half of 2011 compared to 2010 in all of our segments with the
largest increases coming from Industrial Systems, Aircraft Controls and Space and Defense Controls.
Our gross margin was relatively unchanged in the second quarter and first half of 2011 compared to
2010, reflecting volume increases and a more favorable product mix, offset by additions to contract
loss reserves. The loss reserves are primarily related to our Aircraft Controls segment.
Research and development expenses increased in the second quarter of 2011 compared to 2010, from
the Airbus A350 program. For the first half of 2011, the increase in research and development
expense was partially offset by $5 million of reimbursements for a commercial transport program.
Interest expense decreased in the second quarter and first half of 2011 from the same periods in
2010 as a result of lower average borrowings and lower interest rates.
2011 Outlook We expect sales in 2011 to increase by 7% to $2.27 billion reflecting increases in
all of our segments except Components. We expect operating margins to improve to 10.7% in 2011
compared to 10.2% in 2010. We expect operating margins to increase in Space and Defense Controls
and Industrial Systems, remain relatively flat in Aircraft Controls and Medical Devices and
decrease in Components. We expect net earnings to increase to $129 million and diluted earnings per
share to increase by 19% to $2.80.
21
SEGMENT RESULTS OF OPERATIONS AND OUTLOOK
Operating profit, as presented below, is net sales less cost of sales and other operating expenses,
excluding interest expense, equity-based compensation expense and other corporate expenses. Cost of
sales and other operating expenses are directly identifiable to the respective segment or allocated
on the basis of sales, number of employees or profit. Operating profit is reconciled to earnings
before income taxes in Note 15 of the Notes to Consolidated Condensed Financial Statements included
in this report.
Aircraft Controls
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
$ |
|
% |
|
April 2, |
|
April 3, |
|
$ |
|
% |
(dollars in millions) |
|
2011 |
|
2010 |
|
Variance |
|
Variance |
|
2011 |
|
2010 |
|
Variance |
|
Variance |
|
Net sales military aircraft |
|
$ |
122.6 |
|
|
$ |
114.0 |
|
|
$ |
8.6 |
|
|
|
8 |
% |
|
$ |
236.7 |
|
|
$ |
222.7 |
|
|
$ |
14.0 |
|
|
|
6 |
% |
Net sales commercial aircraft |
|
|
73.8 |
|
|
|
64.8 |
|
|
|
9.0 |
|
|
|
14 |
% |
|
|
148.1 |
|
|
|
122.1 |
|
|
|
26.0 |
|
|
|
21 |
% |
Net sales navigation aids |
|
|
9.7 |
|
|
|
10.0 |
|
|
|
(0.3 |
) |
|
|
(3 |
%) |
|
|
17.2 |
|
|
|
19.0 |
|
|
|
(1.8 |
) |
|
|
(9 |
%) |
|
|
|
$ |
206.1 |
|
|
$ |
188.8 |
|
|
$ |
17.3 |
|
|
|
9 |
% |
|
$ |
402.0 |
|
|
$ |
363.8 |
|
|
$ |
38.2 |
|
|
|
11 |
% |
Operating profit |
|
$ |
19.2 |
|
|
$ |
19.6 |
|
|
$ |
(0.4 |
) |
|
|
(2 |
%) |
|
$ |
39.4 |
|
|
$ |
37.2 |
|
|
$ |
2.2 |
|
|
|
6 |
% |
Operating margin |
|
|
9.3 |
% |
|
|
10.4 |
% |
|
|
|
|
|
|
|
|
|
|
9.8 |
% |
|
|
10.2 |
% |
|
|
|
|
|
|
|
|
Backlog |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
569.0 |
|
|
$ |
510.6 |
|
|
$ |
58.4 |
|
|
|
11 |
% |
Within military aircraft sales, aftermarket sales increased $19 million, or 55%, in the second
quarter of 2011 compared to 2010. The increase in the military aftermarket was unusually large and
we do not expect the sales levels to be as high for the remainder of the year. This increase was
partially offset by a $4 million decrease on the F-35 program as it shifts from development to
production and a $3 million decrease on the F-15 program. Commercial aircraft sales were strong as
sales increased $5 million from the ramp up of production on the Boeing 787, $3 million in
aftermarket due to depressed levels in 2010 and $2 million in business jets as that market
recovers.
Military aircraft sales increased $28 million in aftermarket for the first half of 2011 compared to
2010, partially offset by a $6 million decrease on the F-15 program and a $5 million decrease on
the F-35 program. Commercial aircraft sales were strong as aftermarket sales increased $11 million,
due to both an unusual order in 2011 and depressed levels in 2010. In addition, sales increased $10
million for the Boeing 787 production ramp up. Navigation aids decreased due to delays in contract
awards.
Our operating margin was lower in the second quarter and first half of 2011 compared to 2010,
reflecting additions to contract loss reserves that were $4 million higher in the quarter and $11
million higher in the first six months. The higher loss reserves are
on various commercial programs, including the 787 and G250 as a
result of changes coming out of flight tests. Partially offsetting those
reserve additions are benefits associated with higher volume, sales mix changes toward higher
margin business such as military aftermarket, restructuring charges incurred in 2010 and lower
research and development as a percentage of sales, primarily the result of reimbursements totaling
$5 million on a commercial transport program in the first six months of 2011.
The higher level of twelve-month backlog for Aircraft Controls at April 2, 2011 compared to April
3, 2010 reflects strong military and commercial aircraft orders.
2011 Outlook for Aircraft Controls We expect sales in Aircraft Controls to increase 7% to $811
million in 2011. Military aircraft sales are expected to increase 3% to $471 million. We expect a
sales increase in military aftermarket, primarily from the strong first half, offset by a decrease
on the F-15 program. Commercial aircraft sales are expected to increase 15% to $302 million with
increases in almost all product lines, including aftermarket, Boeing 787 and Airbus. Navigation
aids are expected to increase $1 million. We expect our operating margin to be 10.2% in 2011,
relatively flat compared to the 10.1% achieved in 2010, reflecting a more favorable sales mix,
offset by higher contract loss reserves.
22
Space and Defense Controls
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
$ |
|
% |
|
April 2, |
|
April 3, |
|
$ |
|
% |
(dollars in millions) |
|
2011 |
|
2010 |
|
Variance |
|
Variance |
|
2011 |
|
2010 |
|
Variance |
|
Variance |
|
Net sales |
|
$ |
87.8 |
|
|
$ |
79.1 |
|
|
$ |
8.7 |
|
|
|
11 |
% |
|
$ |
183.5 |
|
|
$ |
148.6 |
|
|
$ |
34.9 |
|
|
|
23 |
% |
Operating profit |
|
$ |
13.1 |
|
|
$ |
8.7 |
|
|
$ |
4.4 |
|
|
|
51 |
% |
|
$ |
28.9 |
|
|
$ |
16.2 |
|
|
$ |
12.7 |
|
|
|
78 |
% |
Operating margin |
|
|
14.9 |
% |
|
|
11.0 |
% |
|
|
|
|
|
|
|
|
|
|
15.7 |
% |
|
|
10.9 |
% |
|
|
|
|
|
|
|
|
Backlog |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
205.4 |
|
|
$ |
208.4 |
|
|
$ |
(3.0 |
) |
|
|
(1 |
%) |
Net sales in Space and Defense Controls increased in the second quarter in two main areas,
tactical missiles and security and surveillance. Tactical missiles increased $8 million as the
replenishment of missile inventory related to the Middle East continued. Security and surveillance
increased $7 million, the largest portion resulting from our Pieper acquisition in Germany in the
third quarter of 2010. Partially offsetting those increases was a $3 million decline in the
satellite market which experienced a record year in 2010.
Net sales in Space and Defense Controls increased significantly in the first half of 2011,
primarily in three areas, tactical missiles, the Drivers Vision Enhancer (DVE) program and
security and surveillance. Tactical missiles increased $16 million as a result of a large order for
an aircraft stores management system and the replenishment of missile inventory. Sales on the DVE
program were $15 million higher compared to 2010. In addition, sales increased $12 million in
security and surveillance, primarily a result of our Pieper acquisition.
Our operating margin for Space and Defense Controls increased significantly in the second quarter
and first half of 2011 as a result of the higher sales volume, in particular the volume and
profitability of the DVE program sales in 2011. In addition, we had been waiting for export
approval on the aircraft stores management system. Approval was granted in the first quarter of
2011 which eliminated a significant program risk, thereby allowing us to adjust the profit rate.
The level of twelve-month backlog at April 2, 2011 is comparable to April 3, 2010 as increased
orders for satellites were offset by decreases in launch vehicles.
2011 Outlook for Space and Defense Controls We expect sales in Space and Defense Controls to
increase $32 million, or 10%, to $358 million in 2011. We expect sales increases in tactical
missiles and in security and surveillance, primarily from the Pieper acquisition, which will offset
a decline in satellites. We expect our operating margin in 2011 to increase to 13.3% from 11.0% in
2010, primarily the result of the strong first half.
23
Industrial Systems
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
$ |
|
% |
|
April 2, |
|
April 3, |
|
$ |
|
% |
(dollars in millions) |
|
2011 |
|
2010 |
|
Variance |
|
Variance |
|
2011 |
|
2010 |
|
Variance |
|
Variance |
|
Net sales |
|
$ |
155.9 |
|
|
$ |
120.4 |
|
|
$ |
35.5 |
|
|
|
29 |
% |
|
$ |
299.6 |
|
|
$ |
256.8 |
|
|
$ |
42.8 |
|
|
|
17 |
% |
Operating profit |
|
$ |
15.9 |
|
|
$ |
8.1 |
|
|
$ |
7.8 |
|
|
|
96 |
% |
|
$ |
30.3 |
|
|
$ |
19.3 |
|
|
$ |
11.0 |
|
|
|
57 |
% |
Operating margin |
|
|
10.2 |
% |
|
|
6.8 |
% |
|
|
|
|
|
|
|
|
|
|
10.1 |
% |
|
|
7.5 |
% |
|
|
|
|
|
|
|
|
Backlog |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
264.3 |
|
|
$ |
237.2 |
|
|
$ |
27.1 |
|
|
|
11 |
% |
Net sales in Industrial Systems for the second quarter reflect increases in all of our major
markets except for test equipment. The broad-based sales recovery reflects the strengthening of
business in all of our major geographic markets. Sales increased $8 million in wind energy with
most of the growth coming in Europe, $7 million in motion simulation, $4 million each in metal
forming presses and plastics making machinery and $3 million in heavy industry.
Net sales in Industrial Systems for the first half reflects increases in all of our major markets
except for wind energy. Sales increased $8 million each in motion simulation and metal forming
presses, $6 million in plastics making machinery, $5 million each in power generation and
distribution and $4 million in heavy industry. Offsetting those increases was a decrease in wind
energy of $7 million, primarily due to the Chinese market, where large customers had built up
inventory, allowing them to slow their orders.
Our operating margin for Industrial Systems increased in the second quarter and first half of 2011
primarily as a result of the higher sales volume associated with the economic recovery.
The higher level of twelve-month backlog for Industrial Systems at April 2, 2011 compared to April
3, 2010 is due primarily to increased demand in most of our major markets due to improving global
economic conditions.
2011 Outlook for Industrial Systems We expect sales in Industrial Systems to increase 13% to
$616 million in 2011. We expect sales increases in most major markets, with the largest increases
in motion simulators, test equipment and metal forming and presses, offset by a small decline in
wind energy. While test equipment sales were not particularly strong in the first half of 2011, we
were awarded a contract which will generate strong sales beginning later in 2011. We expect that
our operating margin will increase to 10.4% in 2011 from 8.8% in 2010 as a result of the higher
sales volume.
24
Components
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
$ |
|
% |
|
April 2, |
|
April 3, |
|
$ |
|
% |
(dollars in millions) |
|
2011 |
|
2010 |
|
Variance |
|
Variance |
|
2011 |
|
2010 |
|
Variance |
|
Variance |
|
Net sales |
|
$ |
90.3 |
|
|
$ |
89.8 |
|
|
$ |
0.5 |
|
|
|
1 |
% |
|
$ |
176.7 |
|
|
$ |
174.7 |
|
|
$ |
2.0 |
|
|
|
1 |
% |
Operating profit |
|
$ |
13.3 |
|
|
$ |
14.4 |
|
|
$ |
(1.1 |
) |
|
|
(8 |
%) |
|
$ |
28.1 |
|
|
$ |
26.5 |
|
|
$ |
1.6 |
|
|
|
6 |
% |
Operating margin |
|
|
14.7 |
% |
|
|
16.0 |
% |
|
|
|
|
|
|
|
|
|
|
15.9 |
% |
|
|
15.2 |
% |
|
|
|
|
|
|
|
|
Backlog |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
168.7 |
|
|
$ |
164.1 |
|
|
$ |
4.6 |
|
|
|
3 |
% |
Net sales in Components increased marginally in the second quarter; however, we experienced a
sales shift from defense to industrial markets. Sales in the marine market, which relate to off
shore oil exploration and is closely tied to oil prices, increased $4 million. Sales also increased
$4 million in our industrial business from the general automation and closed circuit TV
surveillance markets. Medical sales increased $1 million from sales to Respironics for sleep apnea
equipment. Sales in the military aircraft market declined $6 million. Sales for defense controls
declined $5 million, mostly a result of slowing demand for various military vehicles and as we
complete our upgrade program on the Bradley Fighting Vehicle.
Net sales in Components increased marginally in the first half of 2011 from last year; however, we
experienced a sales shift between markets similar to the shifts noted for the second quarter. Sales
increased $8 million in our industrial business, $5 million in the marine market and $4 million in
medical equipment, primarily from sales to Respironics. Sales for space and defense controls
declined $10 million, mostly a result of slowing demand for various military vehicles and for a
large fiber optic modem order we supplied in 2010 which did not repeat in 2011. Sales in the
aircraft market declined $6 million, primarily in military aircraft, reflecting strong de-icing
sales on the Black Hawk helicopter program in 2010 and a general softness in 2011. The decline in
military aircraft sales was partially offset by increases in the commercial market.
Our operating margin decreased in the second quarter of 2011 compared to 2010 as a result of the
sales mix shift, primarily from less revenue on the Eurofighter and more revenue on lower margin
commercial motors. Our operating margin for the first half of the year increased generally as a
result of the sales mix shift toward higher margin industrial and marine markets and away from
defense controls.
The marginally higher level of twelve-month backlog at April 2, 2011 compared to April 3, 2010
primarily relates to increased orders for the Guardian system.
2011 Outlook for Components We expect sales in Components to decrease by $10 million in 2011. We
expect sales will decrease in both aircraft and space and defense controls as several major
military aircraft and vehicle programs wind down. Partially offsetting those declines are expected
sales increases in industrial, medical and marine markets. We expect our operating margin in 2011
to be 15.2%, lower than the 16.7% we achieved in 2010 due to the lower sales volume.
25
Medical Devices
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
$ |
|
% |
|
April 2, |
|
April 3, |
|
$ |
|
% |
(dollars in millions) |
|
2011 |
|
2010 |
|
Variance |
|
Variance |
|
2011 |
|
2010 |
|
Variance |
|
Variance |
|
Net sales |
|
$ |
34.2 |
|
|
$ |
32.3 |
|
|
$ |
1.9 |
|
|
|
6 |
% |
|
$ |
66.9 |
|
|
$ |
61.7 |
|
|
$ |
5.2 |
|
|
|
8 |
% |
Operating (loss) profit |
|
$ |
(1.5 |
) |
|
$ |
|
|
|
$ |
(1.5 |
) |
|
|
(100 |
%) |
|
$ |
(3.0 |
) |
|
$ |
0.2 |
|
|
$ |
(3.2 |
) |
|
|
(1600 |
%) |
Operating margin |
|
|
(4.4 |
%) |
|
|
0.0 |
% |
|
|
|
|
|
|
|
|
|
|
(4.5 |
%) |
|
|
0.2 |
% |
|
|
|
|
|
|
|
|
Backlog |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
9.4 |
|
|
$ |
11.0 |
|
|
$ |
(1.6 |
) |
|
|
(15 |
%) |
|
Net sales in Medical Devices increased primarily from strength in the sensors and hand pieces
market, which increased $2 million in the second quarter and $4 million in the first half of 2011
compared to the same periods in 2010. In addition, sales of administration sets increased $1
million in the quarter and $3 million for the first half of the year. Sales of pumps declined $1
million in the quarter and $2 million for the first half of the year as we held shipments on one of
our infusion pumps pending resolution of a software issue.
Our operating margin declined in 2011 relative to 2010 for both the quarter and first half of the
year despite the sales increase. We recorded a $1 million reserve in 2011 in connection with the infusion pump
recall. In addition, lack of sales for this IV pump, most noticeably in the second quarter, changed our sales mix which negatively
impacted margins.
Twelve-month backlog for Medical Devices is not as substantial relative to sales as in our other
segments, reflecting the shorter order-to-shipment cycle for this line of business.
2011 Outlook for Medical Devices We expect sales in Medical Devices to increase 5% to $133
million in 2011. We expect sales increases from the introduction of an additional enteral pump to
the international market and increases in sensors and hand pieces and administration sets. These
increases will be offset by a decrease in infusion pump sales related to the recall. We expect our
operating margin to be (3.4%), relatively unchanged from 2010 as cost improvements will be offset
by a sales mix shift and reserves for the infusion pump software issue.
26
FINANCIAL CONDITION AND LIQUIDITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
April 2, |
|
April 3, |
|
$ |
|
% |
(dollars in millions) |
|
2011 |
|
2010 |
|
Variance |
|
Variance |
|
Net cash provided (used) by: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating activities |
|
$ |
75.9 |
|
|
$ |
83.8 |
|
|
$ |
(7.9 |
) |
|
|
(9 |
%) |
Investing activities |
|
|
(37.8 |
) |
|
|
(28.6 |
) |
|
|
(9.2 |
) |
|
|
32 |
% |
Financing activities |
|
|
(53.0 |
) |
|
|
(46.1 |
) |
|
|
(6.9 |
) |
|
|
15 |
% |
|
Our available borrowing capacity and our cash flow from operations provide us with the
financial resources needed to run our operations, reinvest in our business and make strategic
acquisitions.
Operating activities
Net cash provided by operating activities decreased in 2011 compared to 2010. The decrease is
attributable to higher working capital requirements, primarily in inventory due to increased sales
in 2011. In 2010, we were impacted by lower sales as we began to recover from the recession. This
decrease was partially offset by the higher earnings and non-cash charges in 2011.
Investing activities
Net cash used by investing activities in the first half of 2011 increased primarily from increased
capital expenditures, including test equipment on the A350, and a small acquisition to complement
our military aftermarket business in Aircraft Controls.
Financing activities
The increase in net cash used by financing activities in the first half of 2011 primarily reflects
larger paydowns on our U.S. credit facility.
Off Balance Sheet Arrangements
We do not have any material off balance sheet arrangements that have or are reasonably likely to
have a material future effect on our results of operations or financial condition.
Contractual Obligations and Commercial Commitments
Our contractual obligations and commercial commitments have not changed materially from the
disclosures in our 2010 Form 10-K.
27
CAPITAL STRUCTURE AND RESOURCES
We maintain bank credit facilities to fund our short and long-term capital requirements, including
for acquisitions. From time to time, we also sell equity and debt securities to fund acquisitions
or take advantage of favorable market conditions.
On March 18, 2011, we amended our U.S. credit facility. Previously, our credit facility consisted
of a $750 million revolver, which matured on March 14, 2013. Our new revolving credit facility,
which matures on March 18, 2016, increased our borrowing capacity to $900 million. The new
revolving credit facility had an outstanding balance of $332 million at April 2, 2011. Interest on
the majority of the outstanding credit facility borrowings is based on LIBOR plus the applicable
margin, which was 175 basis points at April 2, 2011. The credit facility is secured by
substantially all of our U.S. assets.
The U.S. credit facility contains various covenants. The covenant for minimum interest coverage
ratio, defined as the ratio of EBITDA to interest expense for the most recent four quarters, is
3.0. The covenant for the maximum leverage ratio, defined as the ratio of net debt, including
letters of credit, to EBITDA for the most recent four quarters, is 3.5. The covenant for maximum
capital expenditures is $135 million for 2011 and increases by $10 million each year thereafter. We
are in compliance with all covenants. EBITDA is defined in the loan agreement as (i) the sum of net
income, interest expense, income taxes, depreciation expense, amortization expense, other non-cash
items reducing consolidated net income and non-cash equity-based compensation expenses minus (ii)
other non-cash items increasing consolidated net income.
We are required to obtain the consent of lenders in the U.S. credit facility before raising
significant additional debt financing. In recent years, we have demonstrated our ability to secure
consents to access debt markets. We have also been successful in accessing equity markets from time
to time. We believe that we will be able to obtain additional debt or equity financing as needed.
At April 2, 2011, we had $573 million of unused borrowing capacity, including $556 million from the
U.S. credit facility after considering standby letters of credit.
Net debt to capitalization was 34% at April 2, 2011 and 36% at October 2, 2010. The decrease in net
debt to capitalization is primarily due to debt reductions funded by our positive cash flow and net
earnings in the first six months of 2011.
We believe that our cash on hand, cash flows from operations and available borrowings under short
and long-term lines of credit will continue to be sufficient to meet our operating needs.
28
ECONOMIC CONDITIONS AND MARKET TRENDS
We operate within the aerospace and defense, industrial and medical markets. Our aerospace and
defense markets are affected by market conditions and program funding levels, while our industrial
markets are influenced by general capital investment trends. Our medical markets are influenced by
economic conditions, population demographics, medical advances and patient demand. A common factor
throughout our markets is the continuing demand for technologically advanced products.
Aerospace and Defense
Approximately 62% of our 2010 sales were generated in aerospace and defense markets. The military
aircraft market is dependent on military spending for development and production programs.
Production programs are typically long-term in nature, offering predictability as to capacity needs
and future revenues. We maintain positions on numerous high priority programs, including the F-35
Joint Strike Fighter, F/A-18E/F Super Hornet and V-22 Osprey. The large installed base of our
products leads to attractive aftermarket sales and service opportunities. Aftermarket revenues are
expected to continue to grow due to a number of scheduled military retrofit programs and increased
flight hours resulting from increased military commitments.
The commercial OEM market has historically exhibited cyclical swings and sensitivity to economic
conditions. The aftermarket is driven by usage of the existing aircraft fleet, the age of the
installed fleet and is currently being impacted by fleet re-sizing programs for passenger and cargo
aircraft. Changes in aircraft utilization rates affect the need for maintenance and spare parts and
impact aftermarket sales. Boeing and Airbus have historically adjusted production in line with air
traffic volume.
The military and government space market is primarily dependent on the authorized levels of funding
for satellite communications. Government spending on military satellites has risen in recent years
as the militarys need for improved intelligence gathering has increased. The commercial space
market is comprised of large satellite customers, traditionally telecommunications companies.
Trends for this market, as well as for commercial launch vehicles, follow the telecommunications
companies need for increased capacity and the satellite replacement lifecycle of 7-10 years. Our
position on NASA programs are impacted by the uncertainty and delays resulting from the
Administrations re-definition of those programs; however, they hold the potential to be long-run
production programs.
The tactical missile, missile defense and defense controls markets are dependent on many of the
same market conditions as military aircraft, including overall military spending and program
funding levels. Our homeland security product line is dependent on government funding at federal
and local levels, as well as private sector demand.
Industrial
Approximately 30% of our 2010 sales were generated in industrial markets. The industrial markets we
serve are influenced by several factors, including capital investment, product innovation, economic
growth, cost-reduction efforts and technology upgrades. We are experiencing challenges from current
global economic conditions which includes reacting to the demands for industrial automation
equipment and steel and automotive manufacturing. Those markets were impacted by the global
recession in 2009 and have continued to recover since then.
Medical
Approximately 8% of our 2010 sales were generated in medical markets. The medical markets we serve
are influenced by economic conditions, hospital and outpatient clinic spending on equipment,
population demographics, medical advances, patient demands and the need for precision control
components and systems. Advances in medical technology and medical treatments have had the effect
of extending the average life span, in turn resulting in greater need for medical services. These
same technology and treatment advances also drive increased demand from the general population as a
means to improve quality of life. Greater access to medical insurance, whether through government
funded health care plans or private insurance, also increases the demand for medical services.
29
Foreign Currencies
We are affected by the movement of foreign currencies compared to the U.S. dollar, particularly in
Industrial Systems. About one-third of our 2010 sales were denominated in foreign currencies.
During the first six months of 2011, foreign currencies generally were unchanged versus the U.S.
dollar compared to the first six months of 2010. The translation of the results of our foreign
subsidiaries into U.S. dollars had no impact on sales compared to the same period one year ago.
30
Cautionary Statement
Information included or incorporated by reference in this report that does not consist of
historical facts, including statements accompanied by or containing words such as may, will,
should, believes, expects, expected, intends, plans, projects, approximate,
estimates, predicts, potential, outlook, forecast, anticipates, presume and assume,
are forward-looking statements. Such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are not
guarantees of future performance and are subject to several factors, risks and uncertainties, the
impact or occurrence of which could cause actual results to differ materially from the expected
results described in the forward-looking statements. These important factors, risks and
uncertainties include:
|
|
|
fluctuations in general business cycles for commercial aircraft, military aircraft,
space and defense products, industrial capital goods and medical devices; |
|
|
|
our dependence on government contracts that may not be fully funded or may be
terminated; |
|
|
|
our dependence on certain major customers, such as The Boeing Company and Lockheed
Martin, for a significant percentage of our sales; |
|
|
|
delays by our customers in the timing of introducing new products, which may affect our
earnings and cash flow; |
|
|
|
the possibility that the demand for our products may be reduced if we are unable to
adapt to technological change; |
|
|
|
intense competition, which may require us to lower prices or offer more favorable terms
of sale; |
|
|
|
our indebtedness, which could limit our operational and financial flexibility; |
|
|
|
the possibility that new product and research and development efforts may not be
successful, which could reduce our sales and profits; |
|
|
|
increased cash funding requirements for pension plans, which could occur in future years
based on assumptions used for our defined benefit pension plans, including returns on plan
assets and discount rates; |
|
|
|
a write-off of all or part of our goodwill or intangible assets, which could adversely
affect our operating results and net worth. |
|
|
|
the potential for substantial fines and penalties or suspension or debarment from future
contracts in the event we do not comply with regulations relating to defense industry
contracting; |
|
|
|
the potential for cost overruns on development jobs and fixed-price contracts and the
risk that actual results may differ from estimates used in contract accounting; |
|
|
|
the possibility that our subcontractors may fail to perform their contractual
obligations, which may adversely affect our contract performance and our ability to obtain
future business; |
|
|
|
our ability to successfully identify and consummate acquisitions, and integrate the
acquired businesses and the risks associated with acquisitions, including that the acquired
businesses do not perform in accordance with our expectations, and that we assume unknown
liabilities in connection with acquired businesses for which we are not indemnified; |
|
|
|
our dependence on our management team and key personnel; |
|
|
|
the possibility of a catastrophic loss of one or more of our manufacturing facilities; |
|
|
|
the possibility that future terror attacks, war or other civil disturbances could
negatively impact our business; |
|
|
|
that our operations in foreign countries could expose us to political risks and adverse
changes in local, legal, tax and regulatory schemes; |
|
|
|
the possibility that government regulation could limit our ability to sell our products
outside the United States; |
|
|
|
product quality or patient safety issues with respect to our medical devices business
that could lead to product recalls, withdrawal from certain markets, delays in the
introduction of new products, sanctions, litigation, declining sales or actions of
regulatory bodies and government authorities; |
|
|
|
the impact of product liability claims related to our products used in applications
where failure can result in significant property damage, injury or death and in damage to
our reputation; |
|
|
|
changes in medical reimbursement rates of insurers to medical service providers, which
could affect sales of our medical products; |
|
|
|
the possibility that litigation results may be unfavorable to us; |
|
|
|
our ability to adequately enforce our intellectual property rights and the possibility
that third parties will assert intellectual property rights that prevent or restrict our
ability to manufacture, sell, distribute or use our products or technology; |
|
|
|
foreign currency fluctuations in those countries in which we do business and other risks
associated with international operations; |
|
|
|
the cost of compliance with environmental laws; |
|
|
|
the risk of losses resulting from maintaining significant amounts of cash and cash
equivalents at financial institutions that are in excess of amounts insured by governments; |
|
|
|
our ability to meet the restrictive covenants under our credit facilities since a breach
of any of these covenants could result in a default under our credit agreements; and |
|
|
|
our customers inability to continue operations or to pay us due to adverse economic
conditions or their inability to access available credit. |
31
These factors are not exhaustive. New factors, risks and uncertainties may emerge from time to time
that may affect the forward-looking statements made herein. Given these factors, risks and
uncertainties, investors should not place undue reliance on forward-looking
statements as predictive of future results. We disclaim any obligation to update the
forward-looking statements made in this report.
|
|
|
Item 3. |
|
Quantitative and Qualitative Disclosures about Market Risk. |
Refer to the Companys Annual Report on Form 10-K for the year ended October 2, 2010 for a complete
discussion of our market risk. There have been no material changes in the current year regarding
this market risk information.
|
|
|
Item 4. |
|
Controls and Procedures. |
(a) |
|
Disclosure Controls and Procedures. We
carried out an evaluation, under the
supervision and with the participation
of our management, including the Chief
Executive Officer and Chief Financial
Officer, of the effectiveness of the
design and operation of our disclosure
controls and procedures as defined in
Exchange Act Rules 13a-15(e) and
15d-15(e). Based on that evaluation,
the Chief Executive Officer and Chief
Financial Officer concluded that these
disclosure controls and procedures are
effective as of the end of the period
covered by this report, to ensure that
information required to be disclosed in
reports filed or submitted under the
Exchange Act is recorded, processed,
summarized and reported within the time
periods specified in the Commissions
rules and forms, and that such
information is accumulated and
communicated to management, including
our Chief Executive Officer and Chief
Financial Officer, as appropriate, to
allow timely decisions regarding
required disclosures. |
|
(b) |
|
Changes in Internal Control over
Financial Reporting. There have been
no changes in our internal control over
financial reporting during the most
recent fiscal quarter that have
materially affected, or are reasonably
likely to materially affect, our
internal control over financial
reporting. |
32
PART II OTHER INFORMATION
|
|
|
Item 2. |
|
Unregistered Sales of Equity Securities and Use of Proceeds. |
(c) The following table summarizes our purchases of our common stock for the quarter ended April 2, 2011.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(d) Maximum |
|
|
|
|
|
|
|
|
|
|
(c ) Total |
|
Number (or |
|
|
|
|
|
|
|
|
|
|
Number of |
|
Approximate |
|
|
|
|
|
|
|
|
|
|
Shares |
|
Dollar Value) of |
|
|
|
|
|
|
|
|
|
|
Purchased as |
|
Shares that May |
|
|
(a) Total |
|
|
|
|
|
Part of Publicly |
|
yet be |
|
|
Number of |
|
(b) Average |
|
Announced |
|
Purchased |
|
|
Shares |
|
Price Paid Per |
|
Plans or |
|
Under the Plans |
Period |
|
Purchased (1)(2) |
|
Share |
|
Programs (3) |
|
or Programs (3) |
|
January 2, 2011 - January 31, 2011 |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
766,400 |
|
February 1, 2011 - February 28, 2011 |
|
|
64,567 |
|
|
$ |
43.88 |
|
|
|
|
|
|
|
766,400 |
|
March 1, 2011 - April 2, 2011 |
|
|
28,362 |
|
|
$ |
44.63 |
|
|
|
|
|
|
|
766,400 |
|
|
Total |
|
|
92,929 |
|
|
$ |
44.11 |
|
|
|
|
|
|
|
766,400 |
|
|
(1) |
|
Purchases in February and March consisted of 40,845 and 13,346
shares of Class B common stock from the Moog Inc. Retirement
Savings Plan at $44.33 and $44.75 per share, respectively.
Purchases in February also include 18,500 shares of Class B common
stock from the Moog family at $42.88 per share. |
|
(2) |
|
In connection with the exercise of stock options, we accept, from
time to time, delivery of shares to pay the exercise price of
employee stock options. During February and March, we accepted
the delivery of 5,222 and 15,016 shares at $43.93 and $44.52 per
share, respectively, in connection with the exercise of stock
options. |
|
(3) |
|
In October 2008, the Board of Directors authorized a share
repurchase program. The program permits the purchase of up to
1,000,000 Class A or Class B common shares in open market or
privately negotiated transactions at the discretion of management. |
(a) Exhibits
|
|
|
10.1
|
|
Third Amended and Restated Loan Agreement, dated as of
March 18, 2011, by and among the Company and the
lenders parties thereto (incorporated by reference to
Exhibit 10.1 to the Companys Current Report on Form
8-K filed March, 21, 2011, Commission File No. 1-5129). |
|
|
|
31.1
|
|
Certification of Chief Executive Officer pursuant to
Exchange Act Rule 13a-14(a) as adopted pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
31.2
|
|
Certification of Chief Financial Officer pursuant to
Exchange Act Rule 13a-14(a) as adopted pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
32.1
|
|
Certification pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002. |
|
|
|
101.INS
|
|
XBRL Instance Document.* |
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document.* |
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.* |
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document.* |
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document.* |
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.* |
|
|
|
* |
|
Submitted electronically herewith. |
33
Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business
Reporting Language):
(i) Consolidated Condensed Statements of Earnings for the three and six months ended April 2, 2011
and April 3, 2010,
(ii) Consolidated Condensed Balance Sheets at April 2, 2011 and October 2, 2010, (iii) Consolidated
Condensed Statements of Cash Flows for the six months ended April 2, 2011 and April 3, 2010 and
(iv) Notes to Consolidated Condensed Financial Statements for the six months ended April 2, 2011.
In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this
Quarterly Report on Form 10-Q shall not be deemed to be filed for purposes of Section 18 of the
Exchange Act, or otherwise subject to the liability of that section and shall not be part of any
registration or other document filed under the Securities Act or the Exchange Act, except as shall
be expressly set forth by specific reference in such filing.
34
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
|
Moog Inc.
|
|
|
(Registrant) |
|
|
|
|
|
|
|
|
|
Date: May 10, 2011 |
By |
/s/ Robert T. Brady
|
|
|
|
Robert T. Brady |
|
|
|
Chairman
Chief Executive Officer
(Principal Executive Officer) |
|
|
|
|
|
Date: May 10, 2011 |
By |
/s/ John R. Scannell
|
|
|
|
John R. Scannell |
|
|
|
President
Chief Operating Officer |
|
|
|
|
|
Date: May 10, 2011 |
By |
/s/ Donald R. Fishback
|
|
|
|
Donald R. Fishback |
|
|
|
Vice President
Chief Financial Officer
(Principal Financial Officer) |
|
|
|
|
|
Date: May 10, 2011 |
By |
/s/ Jennifer Walter
|
|
|
|
Jennifer Walter |
|
|
|
Controller
(Principal Accounting Officer) |
|
|
35